

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 9.98868989 |
| 2 | protein localization to microtubule cytoskeleton (GO:0072698) | 9.23779755 |
| 3 | protein localization to cytoskeleton (GO:0044380) | 7.94508356 |
| 4 | response to gravity (GO:0009629) | 7.52747361 |
| 5 | regulation of synapse structural plasticity (GO:0051823) | 6.74506628 |
| 6 | dopamine biosynthetic process (GO:0042416) | 6.52902028 |
| 7 | skeletal muscle adaptation (GO:0043501) | 6.10398083 |
| 8 | striated muscle atrophy (GO:0014891) | 5.96163889 |
| 9 | skeletal muscle tissue regeneration (GO:0043403) | 5.85124489 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 5.59103128 |
| 11 | protein localization to chromosome (GO:0034502) | 5.38594544 |
| 12 | phenol-containing compound biosynthetic process (GO:0046189) | 5.21508785 |
| 13 | negative regulation of muscle hypertrophy (GO:0014741) | 5.01646054 |
| 14 | muscle atrophy (GO:0014889) | 4.99338443 |
| 15 | prepulse inhibition (GO:0060134) | 4.98114486 |
| 16 | serotonin metabolic process (GO:0042428) | 4.97544948 |
| 17 | response to histamine (GO:0034776) | 4.91550038 |
| 18 | striatum development (GO:0021756) | 4.75879125 |
| 19 | muscle filament sliding (GO:0030049) | 4.72272493 |
| 20 | actin-myosin filament sliding (GO:0033275) | 4.72272493 |
| 21 | microtubule anchoring (GO:0034453) | 4.60040635 |
| 22 | response to activity (GO:0014823) | 4.38591694 |
| 23 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 4.30693382 |
| 24 | auditory behavior (GO:0031223) | 4.30686535 |
| 25 | response to inactivity (GO:0014854) | 4.24557442 |
| 26 | melanin biosynthetic process (GO:0042438) | 4.22878539 |
| 27 | response to muscle activity (GO:0014850) | 4.11303208 |
| 28 | dopamine transport (GO:0015872) | 4.07574399 |
| 29 | catecholamine biosynthetic process (GO:0042423) | 4.04682343 |
| 30 | catechol-containing compound biosynthetic process (GO:0009713) | 4.04682343 |
| 31 | response to xenobiotic stimulus (GO:0009410) | 4.00748138 |
| 32 | secondary metabolite biosynthetic process (GO:0044550) | 3.99483464 |
| 33 | response to auditory stimulus (GO:0010996) | 3.96699537 |
| 34 | negative regulation of microtubule polymerization (GO:0031115) | 3.86659691 |
| 35 | primary amino compound metabolic process (GO:1901160) | 3.86247307 |
| 36 | melanin metabolic process (GO:0006582) | 3.86173443 |
| 37 | monoamine transport (GO:0015844) | 3.78645799 |
| 38 | stress fiber assembly (GO:0043149) | 3.72078980 |
| 39 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.68699397 |
| 40 | actin-mediated cell contraction (GO:0070252) | 3.66232761 |
| 41 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.65277411 |
| 42 | response to nerve growth factor (GO:1990089) | 3.65277411 |
| 43 | brain morphogenesis (GO:0048854) | 3.64037535 |
| 44 | synaptic transmission, dopaminergic (GO:0001963) | 3.59708452 |
| 45 | protein K6-linked ubiquitination (GO:0085020) | 3.37406742 |
| 46 | regulation of dopamine metabolic process (GO:0042053) | 3.34296267 |
| 47 | regulation of catecholamine metabolic process (GO:0042069) | 3.34296267 |
| 48 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.19446931 |
| 49 | dopamine metabolic process (GO:0042417) | 3.15358567 |
| 50 | regulation of RIG-I signaling pathway (GO:0039535) | 3.06516728 |
| 51 | grooming behavior (GO:0007625) | 3.03427894 |
| 52 | cellular response to dexamethasone stimulus (GO:0071549) | 3.03148759 |
| 53 | cytidine metabolic process (GO:0046087) | 3.01114033 |
| 54 | cytidine catabolic process (GO:0006216) | 3.01114033 |
| 55 | cytidine deamination (GO:0009972) | 3.01114033 |
| 56 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.94413516 |
| 57 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.94413516 |
| 58 | tissue regeneration (GO:0042246) | 2.93538772 |
| 59 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.92661362 |
| 60 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.92661362 |
| 61 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.91104996 |
| 62 | neuromuscular process controlling posture (GO:0050884) | 2.86931756 |
| 63 | nucleoside diphosphate catabolic process (GO:0009134) | 2.82797466 |
| 64 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.80558944 |
| 65 | behavioral response to ethanol (GO:0048149) | 2.79096311 |
| 66 | response to dexamethasone (GO:0071548) | 2.74567833 |
| 67 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.72058493 |
| 68 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.67032057 |
| 69 | positive regulation of growth hormone secretion (GO:0060124) | 2.66281880 |
| 70 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.65398823 |
| 71 | regulation of circadian sleep/wake cycle (GO:0042749) | 2.62483849 |
| 72 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.62483849 |
| 73 | myelin assembly (GO:0032288) | 2.61984268 |
| 74 | cellular response to nicotine (GO:0071316) | 2.60691682 |
| 75 | skeletal muscle contraction (GO:0003009) | 2.59804494 |
| 76 | mechanosensory behavior (GO:0007638) | 2.59569637 |
| 77 | righting reflex (GO:0060013) | 2.59396240 |
| 78 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.58978775 |
| 79 | negative regulation of T cell mediated immunity (GO:0002710) | 2.55494401 |
| 80 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.55116900 |
| 81 | thalamus development (GO:0021794) | 2.52503904 |
| 82 | actin filament-based movement (GO:0030048) | 2.50566077 |
| 83 | regulation of centriole replication (GO:0046599) | 2.50441649 |
| 84 | protein polyglutamylation (GO:0018095) | 2.48432479 |
| 85 | peristalsis (GO:0030432) | 2.45987165 |
| 86 | neurofilament cytoskeleton organization (GO:0060052) | 2.45839216 |
| 87 | granulocyte activation (GO:0036230) | 2.45265421 |
| 88 | positive regulation of hormone metabolic process (GO:0032352) | 2.44713172 |
| 89 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.42472150 |
| 90 | regulation of renal sodium excretion (GO:0035813) | 2.41405596 |
| 91 | neurotransmitter uptake (GO:0001504) | 2.40912477 |
| 92 | cellular response to lithium ion (GO:0071285) | 2.40724523 |
| 93 | cardiovascular system development (GO:0072358) | 2.40409312 |
| 94 | oligosaccharide catabolic process (GO:0009313) | 2.37893640 |
| 95 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.37649964 |
| 96 | negative regulation of heart rate (GO:0010459) | 2.36693044 |
| 97 | protein localization to microtubule (GO:0035372) | 18.4128748 |
| 98 | protein localization to kinetochore (GO:0034501) | 15.2127598 |
| 99 | attachment of spindle microtubules to kinetochore (GO:0008608) | 14.5072951 |
| 100 | protein localization to chromosome, centromeric region (GO:0071459) | 11.5248909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 6.70718435 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.04955927 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 5.53138844 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 4.36928771 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.24410402 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.02097663 |
| 7 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.98129820 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.94254267 |
| 9 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.91855425 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50866949 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.48833648 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.37511783 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.25179851 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.25141903 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.16371557 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10908562 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.06077857 |
| 18 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.97695716 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.94628230 |
| 20 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.94230182 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.88031958 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.87247758 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 1.86198334 |
| 24 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.84060931 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80278982 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69391409 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68868094 |
| 28 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.64101819 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48766964 |
| 30 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.47112394 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46853417 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46660624 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43425331 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42375666 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42003343 |
| 36 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40965196 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34596658 |
| 38 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.34378716 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34216737 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33880933 |
| 41 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.30820826 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28179223 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27480603 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26039370 |
| 45 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.24403384 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23965552 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20836850 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18498967 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18296163 |
| 50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17473583 |
| 51 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15785008 |
| 52 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.14384448 |
| 53 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.12789781 |
| 54 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11764341 |
| 55 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08727968 |
| 56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07075963 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06927950 |
| 58 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.06530400 |
| 59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06413279 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05240959 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05107074 |
| 62 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04422689 |
| 63 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03450186 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03040349 |
| 65 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.01901370 |
| 66 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01715628 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99895481 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98604962 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98076327 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.97982765 |
| 71 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.96192301 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95361577 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94620530 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93488983 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93450578 |
| 76 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93180657 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91695516 |
| 78 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.90977485 |
| 79 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89962590 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89646446 |
| 81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89646446 |
| 82 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.88699621 |
| 83 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88574272 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88341620 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.86367276 |
| 86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.85768241 |
| 87 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.83263341 |
| 88 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.82979248 |
| 89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82805307 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82106443 |
| 91 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.81051578 |
| 92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.80220563 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.80220563 |
| 94 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.79158192 |
| 95 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.78933944 |
| 96 | TCF4_23295773_ChIP-Seq_U87_Human | 0.77438961 |
| 97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77179525 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76104467 |
| 99 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.75335761 |
| 100 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.75267856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 4.99622216 |
| 2 | MP0002822_catalepsy | 4.97335734 |
| 3 | MP0001529_abnormal_vocalization | 3.49828674 |
| 4 | MP0005408_hypopigmentation | 3.29213700 |
| 5 | MP0005409_darkened_coat_color | 3.26576497 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.12764073 |
| 7 | MP0002102_abnormal_ear_morphology | 3.06065551 |
| 8 | MP0002089_abnormal_postnatal_growth/wei | 2.82101010 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.81840154 |
| 10 | MP0000015_abnormal_ear_pigmentation | 2.73620520 |
| 11 | MP0002736_abnormal_nociception_after | 2.67237618 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.64441088 |
| 13 | MP0000749_muscle_degeneration | 2.63086075 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.41407070 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.41356098 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.40974677 |
| 17 | MP0000747_muscle_weakness | 2.36815003 |
| 18 | MP0001188_hyperpigmentation | 2.32358693 |
| 19 | MP0001905_abnormal_dopamine_level | 2.32299265 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.26593024 |
| 21 | MP0000013_abnormal_adipose_tissue | 2.10347758 |
| 22 | MP0002095_abnormal_skin_pigmentation | 2.07622037 |
| 23 | MP0005275_abnormal_skin_tensile | 2.07387746 |
| 24 | MP0000750_abnormal_muscle_regeneration | 2.01763317 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.93007395 |
| 26 | MP0004270_analgesia | 1.89221040 |
| 27 | MP0002106_abnormal_muscle_physiology | 1.82408033 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.81646970 |
| 29 | MP0004381_abnormal_hair_follicle | 1.70823120 |
| 30 | MP0002269_muscular_atrophy | 1.62530798 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.59202488 |
| 32 | MP0000759_abnormal_skeletal_muscle | 1.58100479 |
| 33 | MP0005257_abnormal_intraocular_pressure | 1.55492584 |
| 34 | MP0000751_myopathy | 1.54461299 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.45870365 |
| 36 | MP0003786_premature_aging | 1.44843922 |
| 37 | MP0001486_abnormal_startle_reflex | 1.43427304 |
| 38 | MP0000733_abnormal_muscle_development | 1.31315700 |
| 39 | MP0005369_muscle_phenotype | 1.28141358 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.25847731 |
| 41 | MP0004742_abnormal_vestibular_system | 1.24637197 |
| 42 | MP0003959_abnormal_lean_body | 1.24577449 |
| 43 | MP0006054_spinal_hemorrhage | 1.23770938 |
| 44 | MP0004510_myositis | 1.22034723 |
| 45 | MP0005620_abnormal_muscle_contractility | 1.21765325 |
| 46 | MP0003045_fibrosis | 1.20981223 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.20643789 |
| 48 | MP0001243_abnormal_dermal_layer | 1.18524644 |
| 49 | MP0000427_abnormal_hair_cycle | 1.17761393 |
| 50 | MP0008004_abnormal_stomach_pH | 1.14522354 |
| 51 | MP0004087_abnormal_muscle_fiber | 1.13780962 |
| 52 | MP0004036_abnormal_muscle_relaxation | 1.13280994 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.12929187 |
| 54 | MP0000358_abnormal_cell_content/ | 1.10363433 |
| 55 | MP0001958_emphysema | 1.06304452 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.02274791 |
| 57 | MP0005535_abnormal_body_temperature | 1.00512939 |
| 58 | MP0001790_abnormal_immune_system | 1.00050876 |
| 59 | MP0005387_immune_system_phenotype | 1.00050876 |
| 60 | MP0005083_abnormal_biliary_tract | 0.98949267 |
| 61 | MP0002090_abnormal_vision | 0.98880410 |
| 62 | MP0010307_abnormal_tumor_latency | 0.98133032 |
| 63 | MP0000371_diluted_coat_color | 0.97819339 |
| 64 | MP0002938_white_spotting | 0.95699976 |
| 65 | MP0003879_abnormal_hair_cell | 0.93441089 |
| 66 | MP0004484_altered_response_of | 0.92170057 |
| 67 | MP0005377_hearing/vestibular/ear_phenot | 0.88564575 |
| 68 | MP0003878_abnormal_ear_physiology | 0.88564575 |
| 69 | MP0002796_impaired_skin_barrier | 0.88212569 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.84789728 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.82429802 |
| 72 | MP0005197_abnormal_uvea_morphology | 0.81552974 |
| 73 | MP0002108_abnormal_muscle_morphology | 0.79225448 |
| 74 | MP0003724_increased_susceptibility_to | 0.78505683 |
| 75 | MP0002067_abnormal_sensory_capabilities | 0.78220981 |
| 76 | MP0001881_abnormal_mammary_gland | 0.77998835 |
| 77 | MP0001186_pigmentation_phenotype | 0.76144204 |
| 78 | MP0005671_abnormal_response_to | 0.75485191 |
| 79 | MP0005386_behavior/neurological_phenoty | 0.75055447 |
| 80 | MP0004924_abnormal_behavior | 0.75055447 |
| 81 | MP0009745_abnormal_behavioral_response | 0.74468824 |
| 82 | MP0004883_abnormal_blood_vessel | 0.68632537 |
| 83 | MP0005646_abnormal_pituitary_gland | 0.68579443 |
| 84 | MP0003303_peritoneal_inflammation | 0.68247269 |
| 85 | MP0002075_abnormal_coat/hair_pigmentati | 0.67909119 |
| 86 | MP0009764_decreased_sensitivity_to | 0.67451140 |
| 87 | MP0000627_abnormal_mammary_gland | 0.67125345 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.64241449 |
| 89 | MP0006082_CNS_inflammation | 0.64224828 |
| 90 | MP0003011_delayed_dark_adaptation | 0.62911518 |
| 91 | MP0002572_abnormal_emotion/affect_behav | 0.62373748 |
| 92 | MP0010771_integument_phenotype | 0.59747646 |
| 93 | MP0008260_abnormal_autophagy | 0.59500872 |
| 94 | MP0001191_abnormal_skin_condition | 0.59268953 |
| 95 | MP0002272_abnormal_nervous_system | 0.57623184 |
| 96 | MP0005248_abnormal_Harderian_gland | 0.56461434 |
| 97 | MP0005000_abnormal_immune_tolerance | 0.55800339 |
| 98 | MP0008872_abnormal_physiological_respon | 0.54108169 |
| 99 | MP0008874_decreased_physiological_sensi | 0.54064150 |
| 100 | MP0002060_abnormal_skin_morphology | 0.52929440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 7.05297964 |
| 2 | Nemaline bodies (HP:0003798) | 4.82698658 |
| 3 | Mask-like facies (HP:0000298) | 4.80548952 |
| 4 | Entropion (HP:0000621) | 4.68245182 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.54983469 |
| 6 | Distal arthrogryposis (HP:0005684) | 4.44428129 |
| 7 | Limb dystonia (HP:0002451) | 4.35518922 |
| 8 | Neoplasm of the heart (HP:0100544) | 4.11345076 |
| 9 | Bifid tongue (HP:0010297) | 3.97821854 |
| 10 | Absent phalangeal crease (HP:0006109) | 3.76724167 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 3.70142579 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 3.70111365 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.66713001 |
| 14 | Hypopigmentation of the fundus (HP:0007894) | 3.45492112 |
| 15 | Generalized hypopigmentation (HP:0007513) | 3.41518007 |
| 16 | Round ear (HP:0100830) | 3.37305503 |
| 17 | Abnormal finger flexion creases (HP:0006143) | 3.35079168 |
| 18 | Periorbital edema (HP:0100539) | 3.31514580 |
| 19 | Facial edema (HP:0000282) | 3.26013888 |
| 20 | Poikiloderma (HP:0001029) | 3.25857483 |
| 21 | Large for gestational age (HP:0001520) | 3.17424944 |
| 22 | Deformed tarsal bones (HP:0008119) | 3.16959411 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 3.16264407 |
| 24 | Exercise-induced muscle cramps (HP:0003710) | 3.02830928 |
| 25 | Orthostatic hypotension (HP:0001278) | 3.02765441 |
| 26 | Dyschromatopsia (HP:0007641) | 3.00808289 |
| 27 | Hyperkalemia (HP:0002153) | 2.99128344 |
| 28 | Progressive macrocephaly (HP:0004481) | 2.95861469 |
| 29 | Acute encephalopathy (HP:0006846) | 2.92307269 |
| 30 | Ulnar deviation of the wrist (HP:0003049) | 2.84732646 |
| 31 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.82233713 |
| 32 | Microglossia (HP:0000171) | 2.82174003 |
| 33 | Amyotrophic lateral sclerosis (HP:0007354) | 2.78143390 |
| 34 | Abnormality of the axillary hair (HP:0100134) | 2.74310114 |
| 35 | Abnormality of secondary sexual hair (HP:0009888) | 2.74310114 |
| 36 | Ocular albinism (HP:0001107) | 2.74306961 |
| 37 | Iris hypopigmentation (HP:0007730) | 2.74188012 |
| 38 | Abnormality of lateral ventricle (HP:0030047) | 2.67246668 |
| 39 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.64109647 |
| 40 | Abnormal auditory evoked potentials (HP:0006958) | 2.62254089 |
| 41 | Visual hallucinations (HP:0002367) | 2.59273269 |
| 42 | Type 1 muscle fiber predominance (HP:0003803) | 2.54171140 |
| 43 | Paralysis (HP:0003470) | 2.48174484 |
| 44 | Volvulus (HP:0002580) | 2.43919154 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.43268057 |
| 46 | Enlarged kidneys (HP:0000105) | 2.39766612 |
| 47 | Myotonia (HP:0002486) | 2.33827475 |
| 48 | Myoglobinuria (HP:0002913) | 2.28819999 |
| 49 | Abnormality of the peritoneum (HP:0002585) | 2.27274446 |
| 50 | Ectropion (HP:0000656) | 2.26378400 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.25324898 |
| 52 | Renal dysplasia (HP:0000110) | 2.24438113 |
| 53 | Keratitis (HP:0000491) | 2.22131892 |
| 54 | Frequent falls (HP:0002359) | 2.12552898 |
| 55 | Cutaneous melanoma (HP:0012056) | 2.12341959 |
| 56 | Nonprogressive disorder (HP:0003680) | 2.09202153 |
| 57 | Dysautonomia (HP:0002459) | 2.05182266 |
| 58 | Lip pit (HP:0100267) | 2.03704174 |
| 59 | Abnormality of binocular vision (HP:0011514) | 2.03190564 |
| 60 | Diplopia (HP:0000651) | 2.03190564 |
| 61 | Congenital sensorineural hearing impairment (HP:0008527) | 2.01446868 |
| 62 | Corneal dystrophy (HP:0001131) | 2.00180260 |
| 63 | Difficulty running (HP:0009046) | 1.99943858 |
| 64 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.98453643 |
| 65 | Albinism (HP:0001022) | 1.90608317 |
| 66 | Hypoplastic ischia (HP:0003175) | 1.90126202 |
| 67 | Hypoplasia of the uterus (HP:0000013) | 1.88822769 |
| 68 | Cortical visual impairment (HP:0100704) | 1.88709333 |
| 69 | Abnormality of the renal collecting system (HP:0004742) | 1.88389079 |
| 70 | Polyphagia (HP:0002591) | 1.87455745 |
| 71 | Decreased subcutaneous fat (HP:0001002) | 1.87205969 |
| 72 | Fatigue (HP:0012378) | 1.86191187 |
| 73 | Erythroderma (HP:0001019) | 1.83566158 |
| 74 | Mitochondrial inheritance (HP:0001427) | 1.83491854 |
| 75 | Abnormality of the fovea (HP:0000493) | 1.83461983 |
| 76 | Hyperalaninemia (HP:0003348) | 1.83431287 |
| 77 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83431287 |
| 78 | Abnormality of alanine metabolism (HP:0010916) | 1.83431287 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 1.82464759 |
| 80 | Blue irides (HP:0000635) | 1.81196651 |
| 81 | Metatarsus adductus (HP:0001840) | 1.81099198 |
| 82 | Median cleft lip (HP:0000161) | 1.80598459 |
| 83 | Arthropathy (HP:0003040) | 1.78133181 |
| 84 | Rimmed vacuoles (HP:0003805) | 1.78005376 |
| 85 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.76365580 |
| 86 | Fibular hypoplasia (HP:0003038) | 1.76076150 |
| 87 | Short tibia (HP:0005736) | 1.75950081 |
| 88 | Cerebral edema (HP:0002181) | 1.74514169 |
| 89 | Abnormality of potassium homeostasis (HP:0011042) | 1.72659190 |
| 90 | Abnormality of the septum pellucidum (HP:0007375) | 1.70081937 |
| 91 | Joint swelling (HP:0001386) | 1.70019435 |
| 92 | Personality changes (HP:0000751) | 1.69612839 |
| 93 | Mutism (HP:0002300) | 1.69403938 |
| 94 | Recurrent corneal erosions (HP:0000495) | 1.66679209 |
| 95 | Abnormality of the clitoris (HP:0000056) | 1.66035986 |
| 96 | Abnormality of the pubic bones (HP:0003172) | 1.65991051 |
| 97 | Intellectual disability, moderate (HP:0002342) | 1.65849844 |
| 98 | Disinhibition (HP:0000734) | 1.64683265 |
| 99 | Delayed gross motor development (HP:0002194) | 1.63363215 |
| 100 | Focal motor seizures (HP:0011153) | 1.63060514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 8.00113114 |
| 2 | MAP3K11 | 4.47248975 |
| 3 | SIK1 | 3.17445972 |
| 4 | PHKG2 | 2.73354078 |
| 5 | PHKG1 | 2.73354078 |
| 6 | EIF2AK2 | 2.63177520 |
| 7 | MAPK13 | 2.50991754 |
| 8 | MARK1 | 2.47628323 |
| 9 | TAOK1 | 2.29852194 |
| 10 | MAPKAPK3 | 1.96839893 |
| 11 | MST1R | 1.79769129 |
| 12 | FES | 1.63599630 |
| 13 | TYRO3 | 1.62883613 |
| 14 | TAOK2 | 1.62849204 |
| 15 | OBSCN | 1.54961335 |
| 16 | LIMK1 | 1.45309559 |
| 17 | CSF1R | 1.42141173 |
| 18 | MATK | 1.35241968 |
| 19 | TIE1 | 1.28692951 |
| 20 | MAP3K1 | 1.27727424 |
| 21 | TESK1 | 1.24286167 |
| 22 | MAP3K5 | 1.23932724 |
| 23 | CHEK2 | 1.22012246 |
| 24 | MAP3K9 | 1.18536883 |
| 25 | MST4 | 1.15084584 |
| 26 | GRK5 | 1.14193711 |
| 27 | GRK7 | 1.11228550 |
| 28 | PTK2B | 1.09751494 |
| 29 | TGFBR2 | 1.09576923 |
| 30 | CAMK2A | 1.07654684 |
| 31 | CSNK1G3 | 1.06834068 |
| 32 | DAPK1 | 1.02769373 |
| 33 | FGR | 1.02219628 |
| 34 | MAP2K4 | 1.00897234 |
| 35 | CAMK1D | 1.00861317 |
| 36 | DYRK2 | 0.97128027 |
| 37 | SIK3 | 0.95446402 |
| 38 | CSNK1A1L | 0.95112349 |
| 39 | NTRK1 | 0.94618505 |
| 40 | CSNK1G1 | 0.91207663 |
| 41 | IKBKB | 0.88777732 |
| 42 | DYRK1A | 0.88734418 |
| 43 | DMPK | 0.88424071 |
| 44 | GRK6 | 0.87646634 |
| 45 | CAMKK2 | 0.87548108 |
| 46 | MAP3K3 | 0.86008215 |
| 47 | IRAK3 | 0.84353826 |
| 48 | TAF1 | 0.83710500 |
| 49 | BRD4 | 0.82635634 |
| 50 | CHUK | 0.79829222 |
| 51 | CSK | 0.77840630 |
| 52 | MYLK | 0.77532069 |
| 53 | CAMK2G | 0.77508740 |
| 54 | NME2 | 0.77108030 |
| 55 | IRAK2 | 0.74888562 |
| 56 | UHMK1 | 0.74086290 |
| 57 | CSNK1G2 | 0.73254111 |
| 58 | ADRBK2 | 0.71001374 |
| 59 | ADRBK1 | 0.69659190 |
| 60 | FGFR2 | 0.64228076 |
| 61 | BUB1 | 0.63335381 |
| 62 | ILK | 0.61552083 |
| 63 | SYK | 0.60554737 |
| 64 | PRKG1 | 0.58177973 |
| 65 | MAP2K7 | 0.58017217 |
| 66 | DAPK2 | 0.56812527 |
| 67 | JAK1 | 0.56378733 |
| 68 | STK16 | 0.53875689 |
| 69 | PIK3CA | 0.53330344 |
| 70 | CDK3 | 0.53220189 |
| 71 | MAP2K3 | 0.52576672 |
| 72 | MAPK4 | 0.52178985 |
| 73 | CAMK2B | 0.51931105 |
| 74 | DYRK3 | 0.50945811 |
| 75 | AURKA | 0.48610678 |
| 76 | WNK3 | 0.47757749 |
| 77 | TXK | 0.47096380 |
| 78 | FYN | 0.44429089 |
| 79 | PIK3CG | 0.43226194 |
| 80 | CDK18 | 0.40840112 |
| 81 | PDK2 | 0.40561045 |
| 82 | CDK15 | 0.40095365 |
| 83 | JAK3 | 0.38529400 |
| 84 | NEK9 | 0.38488006 |
| 85 | MAPK12 | 0.37694083 |
| 86 | DDR2 | 0.37241980 |
| 87 | PRKACB | 0.36962944 |
| 88 | CDK14 | 0.36849618 |
| 89 | FER | 0.36116271 |
| 90 | YES1 | 0.35577362 |
| 91 | IRAK1 | 0.35542370 |
| 92 | CSNK1D | 0.34331695 |
| 93 | CDK11A | 0.33874773 |
| 94 | KDR | 0.32881746 |
| 95 | PLK2 | 0.32084079 |
| 96 | CAMK1G | 0.32039075 |
| 97 | MARK3 | 0.30715746 |
| 98 | PRKCE | 0.29323929 |
| 99 | STK10 | 0.29269371 |
| 100 | MAPK7 | 0.29077044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.26195057 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.03290507 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.51171817 |
| 4 | Tight junction_Homo sapiens_hsa04530 | 2.32876861 |
| 5 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.25628133 |
| 6 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.25421418 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.23274072 |
| 8 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.12001652 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.07648555 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.06028720 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 1.99963960 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97303857 |
| 13 | Cocaine addiction_Homo sapiens_hsa05030 | 1.88667753 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.72416179 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.72204967 |
| 16 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.61549561 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.44968201 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43343572 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.42304703 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40983519 |
| 21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.39496973 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33531778 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26085588 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25292904 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.24312461 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.23758724 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.20810360 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.20785839 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.16668327 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.15801394 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15149764 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12007659 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11754948 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.09550445 |
| 35 | Adherens junction_Homo sapiens_hsa04520 | 1.09457427 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.06285892 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05909207 |
| 38 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04220531 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.01979419 |
| 40 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.01697092 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.01174318 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.00354258 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98705026 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97221847 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96117291 |
| 46 | GABAergic synapse_Homo sapiens_hsa04727 | 0.95759798 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94726412 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94322803 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.92359804 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 0.90888363 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89790217 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88731468 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87062484 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.87049174 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85957273 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82408153 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81838011 |
| 58 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80995552 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80313230 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79666936 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77196442 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 0.74973999 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74572313 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74491056 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74301252 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73493680 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73409002 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71911659 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71106857 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.70500000 |
| 71 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69008481 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.67889465 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.66566643 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65338761 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65207878 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63997484 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.63867408 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61897827 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59289606 |
| 80 | Shigellosis_Homo sapiens_hsa05131 | 0.58492938 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55869182 |
| 82 | Asthma_Homo sapiens_hsa05310 | 0.54826110 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.53896679 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52682235 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52638668 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51128085 |
| 87 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50010447 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49763445 |
| 89 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.49296794 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47702130 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46837511 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44262100 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43960463 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43338094 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.41925379 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41840238 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40847294 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40820350 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37233240 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35447293 |

